Reverse Transcriptase Inhibitors in Aicardi Goutières Syndrome
The overall objectives are to explore the safety and efficacy of Reverse Transcriptase Inhibitors Tenofovir (TDF)/ Emtricitabine (FTC) administered in AGS affected children 2 to 18 years of age.
100 项与 Emerson Resources, Inc. 相关的临床结果
0 项与 Emerson Resources, Inc. 相关的专利(医药)
100 项与 Emerson Resources, Inc. 相关的药物交易
100 项与 Emerson Resources, Inc. 相关的转化医学